19-55518206-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_001144950.2(SSC5D):c.3930C>T(p.Thr1310Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0021 ( 0 hom., cov: 21)
Exomes 𝑓: 0.00078 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
SSC5D
NM_001144950.2 synonymous
NM_001144950.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0140
Genes affected
SSC5D (HGNC:26641): (scavenger receptor cysteine rich family member with 5 domains) Predicted to enable fibronectin binding activity; laminin binding activity; and scavenger receptor activity. Predicted to be involved in defense response; detection of bacterial lipoprotein; and negative regulation of interleukin-8 production. Predicted to act upstream of or within regulation of interleukin-8 production. Predicted to be located in collagen-containing extracellular matrix. Predicted to be active in extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 19-55518206-C-T is Benign according to our data. Variant chr19-55518206-C-T is described in ClinVar as [Benign]. Clinvar id is 403488.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.014 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SSC5D | NM_001144950.2 | c.3930C>T | p.Thr1310Thr | synonymous_variant | 14/14 | ENST00000389623.11 | NP_001138422.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SSC5D | ENST00000389623.11 | c.3930C>T | p.Thr1310Thr | synonymous_variant | 14/14 | 1 | NM_001144950.2 | ENSP00000374274.4 |
Frequencies
GnomAD3 genomes AF: 0.00207 AC: 228AN: 110394Hom.: 0 Cov.: 21
GnomAD3 genomes
AF:
AC:
228
AN:
110394
Hom.:
Cov.:
21
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00155 AC: 196AN: 126818Hom.: 8 AF XY: 0.00123 AC XY: 84AN XY: 68434
GnomAD3 exomes
AF:
AC:
196
AN:
126818
Hom.:
AF XY:
AC XY:
84
AN XY:
68434
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000780 AC: 1025AN: 1314156Hom.: 0 Cov.: 75 AF XY: 0.000709 AC XY: 459AN XY: 647764
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1025
AN:
1314156
Hom.:
Cov.:
75
AF XY:
AC XY:
459
AN XY:
647764
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00208 AC: 230AN: 110452Hom.: 0 Cov.: 21 AF XY: 0.00222 AC XY: 119AN XY: 53676
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
230
AN:
110452
Hom.:
Cov.:
21
AF XY:
AC XY:
119
AN XY:
53676
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at